Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Teva Pharmaceutical Industries ADR Representing One TEVA

Healthcare
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.


NYSE:TEVA - Post by User

Teva Pharmaceutical Industries ADR Representing One
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(229)
•••
Post by whytestockson May 08, 2024 1:00pm
88 Views
Post# 36029237

Teva Reports First Quarter 2024 Financial Results and Reaffi

Teva Reports First Quarter 2024 Financial Results and Reaffi
News; $TEVA Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial OutlookFor an accessible version of this Press Release, please visit www.tevapharm.com Generics business and AUSTEDO &#xAE; growth lead Q1 2024 performance. Q1 2024 revenues of $3.8 billion reflect an increase of 5% in local currency terms, compared to Q1 2023. Generics business gr...TEVA - Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities